Navigation Links
Migraine Might Lower Breast Cancer Risk
Date:11/6/2008

Lower estrogen levels among sufferers may be the reason why, researchers say

THURSDAY, Nov. 6 (HealthDay News) -- Women who experience migraines may actually have a 30 percent lower risk of developing breast cancer, say researchers from the Fred Hutchinson Cancer Research Center in Seattle.

Levels of estrogen may be the key to this association: High levels of estrogen are associated with an increased risk of breast cancer, but women who suffer migraines appear to have low levels of the hormone, which may account for the reduction in breast cancer risk, the researchers explained.

"Women who suffer migraines suffer them either when they have fluctuations in their hormone levels or particularly low levels of hormones," said lead research epidemiologist Dr. Christopher I. Li.

Li noted that during pregnancy, when estrogen levels are high, migraines often stop. "Among migraine sufferers who reach the third trimester, 80 percent of them will not suffer any migraines," he said.

The report was published in the November issue of Cancer Epidemiology, Biomarkers & Prevention.

Not everyone is convinced that Li's theory is correct.

Dr. Ellen Drexler, associate director of the Division of Neurology at Maimonides Medical Center in Brooklyn, N.Y., doesn't think that estrogen levels explain the association between breast cancer risk and migraine.

"Migraine brains are more sensitive to many exogenous and endogenous factors, of which falling estrogen levels are an important one for many female migraineurs," Drexler said. "However, female migraineurs are not known to have consistently lower levels of estrogen than are non-migraineurs."

It is not clear that the lower incidence of breast cancer in women with migraines proves that the reason is lower estrogen levels, Drexler said.

"Genetic factors may also be playing a role, as well as exogenous factors such as medication use, smoking and alcohol use, which may vary between migraineurs and non-migraineurs," Drexler said. "In summary, an interesting study, but more work needs to be done to conclude that it has furthered our understanding of the biology of migraine or of breast cancer."

For the study, Li's team collected data on 3,412 postmenopausal women. Among these women, 1,938 had been diagnosed with breast cancer, and 1,474 had no history of the disease. The researcher also gathered information about migraines from the women.

The researchers found that women who suffered from migraines had a 30 percent lower risk of developing breast cancer compared with women with no history of migraine.

Li noted that more work needs to be done to nail down the reason for the apparent protective effect of migraine for breast cancer. "Advancing our understanding of the mechanisms of migraine may improve our understanding of how we could potentially reduce breast cancer risk," he said.

Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society, thinks the finding is interesting, but has no clinical implications.

"There is a decreased risk for women with migraines to develop breast cancer," Lichtenfeld said. "But in practical implications -- what should a woman do differently -- there is no action a woman or her health-care professional would take as a result of this report."

Migraine expert Dr. Stephen Silberstein, director of the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, said the findings are flawed, because using self-reported migraine data is not sufficient to determine whether the women actually suffered migraine or not.

"This study doesn't prove anything," Silberstein said. "It's not that I don't believe the results, it's that the results are not believable."

More information

For more on breast cancer, visit the U.S. National Cancer Institute.



SOURCES: Christopher I. Li, M.D., Ph.D., epidemiologist, Fred Hutchinson Cancer Research Center, Seattle; Stephen Silberstein, M.D., director, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia; Ellen Drexler, M.D., associate director, Division of Neurology, Maimonides Medical Center, Brooklyn, N.Y.; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; November 2008, Cancer Epidemiology, Biomarkers & Prevention


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Migraines associated with lower risk of breast cancer
2. Migraine Sufferers Face Greater Blood Clot Risk
3. Army personnel show increased risk for migraine
4. Gene Could Boost Stroke Risk for Migraine Sufferers
5. CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
6. Migraine mutations reveal clues to biological basis of disorder
7. OptiNose presents data on highly effective migraine treatment
8. Portable device effective in zapping away migraine pain
9. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
10. Webinar on June 25 to Focus on Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
11. Migraine Medications May Cause Serotonin Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Migraine Might Lower Breast Cancer Risk
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: